Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Howe Jill Ann bought 20,000 Lineage Cell Therapeutics, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 16, 2026
On Nov 16, 2026, Howe Jill Ann (Chief Financial Officer) bought 20,000 Lineage Cell Therapeutics, Inc. shares at US$0.86 for US$17,100, leaving 45,500 shares. Filed Nov 16, 2026 (Form 4).
- Bought
- 20,000 shares
- Price
- US$0.86
- Value
- US$17,100
- Holding after
- 45,500 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Shares | Buy | 20,000 | US$0.86 | 45,500 | Direct |
Source
Download original · View original at SEC
Related
- Lineage Cell Therapeutics, Inc.
- Howe Jill Ann
- Lineage Cell Therapeutics, Inc. shareholders
- Form 4 · Mulroy Michael H. · Nov 19, 2026
- Form 4 · Broadwood Partners, L.P. · Nov 19, 2026
- Form 4 · Andrews Deborah J · Nov 17, 2026
- Form 4 · Culley Brian M · Nov 17, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026